This is in agreement with the study of Osma et al. [33], in which serum copeptin levels did not decrease significantly in 16 patients with severe OSA (AHI > 30) after 1 year of positive airway pressure treatment (p = 0.156). The gene discussed is AVP; the disease is obstructive sleep apnea syndrome.